[Treatment of gynecologic neoplasms in internal medicine].
In the treatment of gynecological malignancies, chemotherapy is used with increasing frequency. The palliation in advanced stages is limited, but a marked prolongation of survival is proven in patients who achieve remissions. The remission rates of the commonly used agents and their combinations are listed. The use of cytotoxic chemotherapy is recommended in advanced stages of gynecological malignancies. Hormonal therapy offers a nearly nontoxic but less effective alternative to cytotoxic therapy.
D000477:Alkylating Agents / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D002822:Choriocarcinoma / Q000188:drug therapy; D006063:Chorionic Gonadotropin / Q000032:analysis; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy*; D006801:Humans; D008727:Methotrexate; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000532:radiotherapy / Q000601:surgery; D011247:Pregnancy; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000628:therapy
D000477:Alkylating Agents; D006063:Chorionic Gonadotropin; D001761:Bleomycin; D004317:Doxorubicin; D003520:Cyclophosphamide; D008727:Methotrexate
Internistische Behandlung gynäkologischer Malignome.